openPR Logo
Press release

Parkinson's Disease Drug Market to Witness Growth Acceleration by 2031

05-14-2024 02:04 PM CET | Health & Medicine

Press release from: Orion Market Research

Parkinson's Disease Drug Market to Witness Growth Acceleration

The Global Parkinson's disease market is anticipated to grow at a significant CAGR during the forecast. Pharmaceutical firms are developing new and improved therapies for Parkinson's disease (PD). Recently, there have been some major product launches in Parkinson's disease. For instance, in February 2022, Avion Pharmaceuticals LLC announced the commercial launch of DHIVY, the first and only carbidopa/ levodopa (CD/LD) fractional tablet designed to be divided. Avion gained approval for DHIVY from the FDA in Nov 2021. This unique design enables more precise medication for those with Parkinson's disease (PD). Also, government funding for research and massive utilization of L-Dopa, asymptomatic dopamine replacement treatment, and the nigrostriatal system expects a boost to the market in the coming years.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/parkinsons-disease-drug-market

The shifting of research activities from symptomatic treatment to Parkinson's disorder modifying treatment will create growth for Parkinson's disease treatment industry over the forthcoming years. For instance, Kyowa Kirin Co Ltd a Japanese Pharmaceutical and biotechnology company announced the U.S. Food and Drug Administration (FDA) approval for medicine NOURIANZ (istradefylline). For instance, in Feb 2020, Sun Pharma launched severe nodular acne management capsules in the US. It is launched for patients who are below 12 years of age or older. It can be taken with or without food.

Global Parkison's Disease Drug Market Report Segment

By Mechanism of Action

• Dopamine Agonists
• Anticholinergic
• MAO-B Inhibitors
• Amantadine
• Carbidopa-levodopa
• COMT Inhibitors
• Others

A full report of Parkinson's Disease Drug Market is available at: https://www.omrglobal.com/industry-reports/parkinsons-disease-drug-market

Global Parkinson's Disease Drug Market-Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AbbVie Inc
• Apotex Inc
• Axovant Gene Therapies Ltd
• Boston Scientific Corp
• Cipla Inc
• Eisai Co Ltd
• Eli Lily & Co
• Impax Laboratories Inc
• Mylan NV
• Novartis International AG

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.


Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parkinson's Disease Drug Market to Witness Growth Acceleration by 2031 here

News-ID: 3496006 • Views:

More Releases from Orion Market Research

Healthcare Claims Management Market Trends, Latest Insights, Analysis and Forecast 2024-2031
Healthcare Claims Management Market Trends, Latest Insights, Analysis and Foreca …
The global Healthcare Claims Management market is anticipated to grow at a CAGR of 5.2% during the forecast period (2024-2031). As the global population grows and ages, the number of people seeking healthcare services is also increasing. Hence the market demand for better and improved system is rising and market players are focusing on introducing new software in the market. For instance, In April 2023, Google Cloud announced a new
Gynecological Devices Market Increasing Demand, Growth Analysis and Future Outlook by 2031
Gynecological Devices Market Increasing Demand, Growth Analysis and Future Outlo …
The global gynecological devices market is anticipated to grow at a CAGR of 7.9% during the forecast period (2024-2031). Diagnostic imaging devices include ultrasound machines, MRI and CT scanners, hysterosalpingography for evaluating the uterus and fallopian tubes, and colposcopes for examining the cervix. Biopsy devices are used for sampling tissue from the uterus and cervix. Laboratory testing equipment includes Pap smear tests, HPV testing kits, and blood tests for hormonal
GMP Testing Service Market Increasing Demand, Growth Analysis and Future Outlook by 2031
GMP Testing Service Market Increasing Demand, Growth Analysis and Future Outlook …
The global GMP testing service market is anticipated to grow at a CAGR of 6.7% during the forecast period (2024-2031). Testing of drug substances involves analysing active pharmaceutical ingredients (APIs) to assess their quality, purity, and potency. This includes using methods such as chromatography, spectroscopy, and mass spectrometry. Microbiological testing is important to ensure the sterility and safety of pharmaceutical products. Quality control testing is conducted to confirm the quality
Geospatial Analytics Market Trends, Latest Insights, Analysis and Forecast 2024-2031
Geospatial Analytics Market Trends, Latest Insights, Analysis and Forecast 2024- …
The global geospatial analytics market is anticipated to grow at a considerable CAGR of 8.5% during the forecast period (2024-2031). Earth Observation (EO) and geospatial analytics are powerful tools that are being used to transform industries and improve lives across the globe. By making EO data more affordable and accessible, and by investing in research and development, Indian players are accelerating the adoption of EO and geospatial analytics and reap

All 5 Releases


More Releases for Parkinson

QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency. The firm recognised that to continue delivering high quality services to its clients it needed to provide
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global
PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services a …
The Parkinson Research Foundation is pleased to announce that Marilyn Tait has joined the foundation as the Director of Patient Programs, Services and Advocacy. Tait, is a graduate of Thomas Jefferson University School of Nursing in Philadelphia, Pennsylvania. Tait has forty years experience in healthcare marketing and program development. After specializing in oncology for 30 years, Tait embarked on her new career at a time in her life when
PARKINSON RESEARCH FOUNDATION’S (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU …
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field. After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRF’s focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease. The Foundation’s educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affected
Parkinson`s Disease:New Hope Educational Conference
PARKINSON’S DISEASE: NEW HOPE EDUCATIONAL CONFERENCE Become knowledgeable about the advancements in surgery The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinson’s conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinson’s disease and movement disorders. He has an extensive background and